Clinical Trial Update: Belimumab With Rituximab for Primary Membranous Nephropathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of belimumab with rituximab for primary membranous nephropathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy
• Nephrotic Syndrome

Drugs mentioned

• Belimumab (belimumab)
• Rituximab (rituximab)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Membranous Nephropathy, Nephrotic Syndrome | Phase 2 | Status: RECRUITING